Evolutionary biologic changes of gut microbiota in an 'adenoma-carcinoma sequence' mouse colorectal cancer model induced by 1, 2-dimethylhydrazine

Oncotarget

Volumn 8, Issue 1, 2017, Pages 444-457

  Sun, Teng ^b   Liu, Shanglong ^a   Zhou, Yanbing ^a   Yao, Zengwu ^c   Zhang, Dongfeng ^d   Cao, Shougen ^a   Wei, Zhiliang ^a   Tan, Bin ^a   Li, Yi ^a   Lian, Zheng ^e   Wang, Song ^f  

^a QINGDAO UNIVERSITY   (China)

^b QINGDAO MUNICIPAL HOSPITAL   (China)

^c YANTAI YUHUANGDING HOSPITAL   (China)

^d QINGDAO UNIVERSITY MEDICAL COLLEGE   (China)

^e Department of Obstetrics and Gynecology   (China)

^f The Affiliated Linzi District People's Hospital of Binzhou Medical University   (China)

Author keywords

Animal model; Colorectal cancer; Microbiology

Indexed keywords

1,2 DIMETHYLHYDRAZINE; APC PROTEIN; B RAF KINASE; DNA 16S; K RAS PROTEIN; PROTEIN P53; ADENOMATOUS POLYPOSIS COLI PROTEIN, MOUSE; BACTERIAL DNA; BACTERIAL RNA; BRAF PROTEIN, MOUSE; HRAS PROTEIN, MOUSE; PROTEIN P21; RNA 16S;

ADENOMA CARCINOMA SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTEROIDETES; BRAF GENE; CANCER GROWTH; CARCINOGENESIS; COLORECTAL CANCER; CONTROLLED STUDY; DNA DAMAGE; DNA EXTRACTION; DNA SEQUENCE; DOWN REGULATION; ENTEROBACTERIACEAE; FIRMICUTES; GENE EXPRESSION; HISTOLOGY; IMMUNOHISTOCHEMISTRY; INTESTINE EPITHELIUM; INTESTINE FLORA; INTESTINE FUNCTION; MALE; MOLECULAR DYNAMICS; MOLECULAR EVOLUTION; MOUSE; NONHUMAN; ONCOGENE K RAS; PRECANCER; PREVOTELLACEAE; PYROSEQUENCING; RIKENELLACEAE; RUMINOCOCCACEAE; TUMOR SUPPRESSOR GENE; UPREGULATION; ADENOCARCINOMA; ADENOMA; ANIMAL; BACTERIUM; CELL TRANSFORMATION; COLON; COLORECTAL TUMOR; DISEASE EXACERBATION; DYSBIOSIS; EXPERIMENTAL NEOPLASM; GENETICS; INSTITUTE FOR CANCER RESEARCH MOUSE; INTESTINE MUCOSA; METABOLISM; MICROBIOLOGY; PATHOLOGY; SIGNAL TRANSDUCTION; ALISTIPES; APC GENE; CANCER MODEL; MICROBIAL COMMUNITY; MOUSE MODEL; PORPHYROMONADACEAE;

1,2-DIMETHYLHYDRAZINE; ADENOCARCINOMA; ADENOMA; ADENOMATOUS POLYPOSIS COLI PROTEIN; ANIMALS; BACTERIA; CARCINOGENESIS; CELL TRANSFORMATION, NEOPLASTIC; COLON; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; DNA DAMAGE; DNA, BACTERIAL; DYSBIOSIS; GASTROINTESTINAL MICROBIOME; IMMUNOHISTOCHEMISTRY; INTESTINAL MUCOSA; MALE; MICE; MICE, INBRED ICR; NEOPLASMS, EXPERIMENTAL; PROTO-ONCOGENE PROTEINS B-RAF; PROTO-ONCOGENE PROTEINS P21(RAS); RNA, BACTERIAL; RNA, RIBOSOMAL, 16S; SEQUENCE ANALYSIS, DNA; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 85009468161     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015; 136: E359-86. doi: 10.1002/ijc.29210.
2. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. Cancer J Clin. 2015; 65:87-108. doi: 10.3322/caac.21262.
3. Fearon ER. Molecular genetics of colorectal cancer. Annu Rev Pathol. 2011; 6:479-507. doi: 10.1146/annurevpathol- 011110-130235.
4. Vogelstein B, Kinzler KW. The multistep nature of cancer. Trends Genet. 1993; 9:138-41.
5. Stratton MR, Campbell PJ, Futreal PA. The cancer genome. Nature. 2009; 458:719-24. doi: 10.1038/nature07943.
6. Dalton-Griffin L, Kellam P. Infectious causes of cancer and their detection. J Biol. 2009; 8:67. doi: 10.1186/jbiol168.
7. Tjalsma H, Boleij A, Marchesi JR, Dutilh BE. A bacterial driver-passenger model for colorectal cancer: beyond the usual suspects. Nat Rev Microbiol. 2012; 10:575-82. doi: 10.1038/nrmicro2819.
8. Frank DN, St Amand AL, Feldman RA, Boedeker EC, Harpaz N, Pace NR. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci USA. 2007; 104: 13780-5. doi: 10.1073/pnas.0706625104.
9. Neish AS. Microbes in gastrointestinal health and disease. Gastroenterology. 2009; 136:65-80. doi: 10.1053/j. gastro.2008.10.080.
10. Sears CL, Garrett WS. Microbes, Microbiota, and Colon Cancer. Cell Host Microbe. 2014; 15:317-28. doi: 10.1016/j.chom.2014.02.007.
11. Chow J, Lee SM, Shen Y, Khosravi A, Mazmanian SK. Host-bacterial symbiosis in health and disease. Adv Immunol. 2010; 107:243-74. doi: 10.1016/B978-0-12- 381300-8.00008-3.
12. Savage DC. Microbial ecology of the gastrointestinal tract. Annu Rev Microbiol. 1977; 31:107-33. doi: 10.1146/ annurev.mi.31.100177.000543.
13. Kostic AD, Gevers D, Pedamallu CS, Michaud M, Duke F, Earl AM, Ojesina AI, Jung J, Bass AJ, Tabernero J, Baselga J, Liu C, Shivdasani RA, et al. Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. Genome Res. 2012; 22:292-8. doi: 10.1101/ gr.126573.111.
14. Castellarin M, Warren RL, Freeman JD, Dreolini L, Krzywinski M, Strauss J, Barnes R, Watson P, Allen- Vercoe E, Moore RA, Holt RA. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res. 2012; 22:299-306. doi: 10.1101/ gr.126516.111.
15. Marchesi JR, Dutilh BE, Hall N, Peters WH, Roelofs R, Boleij A, Tjalsma H. Towards the human colorectal cancer microbiome. PLoS One. 2011; 6:e20447. doi: 10.1371/ journal.pone.0020447.
16. Kostic AD, Chun E, Robertson L, Glickman JN, Gallini CA, Michaud M, Clancy TE, Chung DC, Lochhead P, Hold GL, El-Omar EM, Brenner D, Fuchs CS, et al. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host Microbe. 2013; 14:207-15. doi: 10.1016/j. chom.2013.07.007.
17. Liang X, Li H, Tian G, Li S. Dynamic microbe and molecule networks in a mouse model of colitis-associated colorectal cancer. Sci Rep. 2014; 4:4985. doi: 10.1038/ srep04985.
18. Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B, Kinzler KW. Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science. 1997; 275:1787-90.
19. Baker SJ, Fearon ER, Nigro JM, Hamilton SR, Preisinger AC, Jessup JM, vanTuinen P, Ledbetter DH, Barker DF, Nakamura Y, White R, Vogelstein B. Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science. 1989; 244:217-21.
20. Krych L, Hansen CH, Hansen AK, van den Berg FW, Nielsen DS. Quantitatively different, yet qualitatively alike: a meta-analysis of the mouse core gut microbiome with a view towards the human gut microbiome. PLoS One. 2013; 8:e62578. doi: 10.1371/journal.pone.0062578.
21. Wu S, Rhee KJ, Albesiano E, Rabizadeh S, Wu X, Yen HR, Huso DL, Brancati FL, Wick E, McAllister F, Housseau F, Pardoll DM, Sears CL. A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat Med. 2009; 15:1016-22. doi: 10.1038/nm.2015.
22. Housseau F, Sears CL. Enterotoxigenic Bacteroides fragilis (ETBF)-mediated colitis in Min (Apc+/-) mice: a human commensal-based murine model of colon carcinogenesis. Cell Cycle. 2010; 9:3-5.
23. Mangan PR, Harrington LE, O'Quinn DB, Helms WS, Bullard DC, Elson CO, Hatton RD, Wahl SM, Schoeb TR, Weaver CT. Transforming growth factor-beta induces development of the T(H)17 lineage. Nature. 2006; 441: 231-4. doi: 10.1038/nature04754.
24. Arthur JC, Perez-Chanona E, Muhlbauer M, Tomkovich S, Uronis JM, Fan TJ, Campbell BJ, Abujamel T, Dogan B, Rogers AB, Rhodes JM, Stintzi A, Simpson KW, et al. Intestinal inflammation targets cancer-inducing activity of the microbiota. Science. 2012; 338:120-3. doi: 10.1126/ science.1224820.
25. de Vos WM, de Vos EA. Role of the intestinal microbiome in health and disease: from correlation to causation. Nutr Rev. 2012; 70:S45-56. doi: 10.1111/j.1753-4887.2012.00505.x.
26. Nougayrede JP, Homburg S, Taieb F, Boury M, Brzuszkiewicz E, Gottschalk G, Buchrieser C, Hacker J, Dobrindt U, Oswald E. Escherichia coli induces DNA double-strand breaks in eukaryotic cells. Science. 2006; 313:848-51. doi: 10.1126/science.1127059.
27. Cuevas-Ramos G, Petit CR, Marcq I, Boury M, Oswald E, Nougayrede JP. Escherichia coli induces DNA damage in vivo and triggers genomic instability in mammalian cells. Proc Natl Acad Sci USA. 2010; 107:11537-42. doi: 10.1073/pnas.1001261107.
28. Mima K, Sukawa Y, Nishihara R, Qian ZR, Yamauchi M, Inamura K, Kim SA, Masuda A, Nowak JA, Nosho K, Kostic AD, Giannakis M, Watanabe H, et al. Fusobacterium nucleatum and T Cells in Colorectal Carcinoma. JAMA Oncol. 2015; 1:653-61. doi: 10.1001/jamaoncol.2015.1377.
29. Mavromatis K, Stackebrandt E, Munk C, Lapidus A, Nolan M, Lucas S, Hammon N, Deshpande S, Cheng JF, Tapia R, Goodwin LA, Pitluck S, Liolios K, et al. Complete genome sequence of the bile-resistant pigment-producing anaerobe Alistipes finegoldii type strain (AHN2437(T)). Stand Genomic Sci. 2013; 8:26-36. doi: 10.4056/ sigs.3527032.
30. Feng Q, Liang S, Jia H, Stadlmayr A, Tang L, Lan Z, Zhang D, Xia H, Xu X, Jie Z, Su L, Li X, Li X, et al. Gut microbiome development along the colorectal adenomacarcinoma sequence. Nat Commun. 2015; 6:6528. doi: 10.1038/ncomms7528.
31. Scheppach W, Luehrs H, Menzel T. Beneficial health effects of low-digestible carbohydrate consumption. Br J Nutr. 2001; 85:S23-30.
32. Mortensen PB, Clausen MR. Short-chain fatty acids in the human colon: relation to gastrointestinal health and disease. Scand J Gastroenterol Suppl. 1996; 216:132-48.
33. Hahnke S, Maus I, Wibberg D, Tomazetto G, Puhler A, Klocke M, Schluter A. Complete genome sequence of the novel Porphyromonadaceae bacterium strain ING2-E5B isolated from a mesophilic lab-scale biogas reactor. J Biotechnol. 2015; 193:34-6. doi: 10.1016/j. jbiotec.2014.11.010.
34. Markowitz SD, Bertagnolli MM. Molecular origins of cancer: Molecular basis of colorectal cancer. N Engl J Med. 2009; 361:2449-60. doi: 10.1056/NEJMra0804588.
35. Lakatos PL, Lakatos L. Risk for colorectal cancer in ulcerative colitis: changes, causes and management strategies. World J Gastroenterol. 2008; 14:3937-47.
36. Sears CL. Enterotoxigenic Bacteroides fragilis: a rogue among symbiotes. Clin Microbiol Rev. 2009; 22:349-69, Table of Contents. doi: 10.1128/CMR.00053-08.
37. Goodwin AC, Destefano Shields CE, Wu S, Huso DL, Wu X, Murray-Stewart TR, Hacker-Prietz A, Rabizadeh S, Woster PM, Sears CL, Casero RA, Jr. Polyamine catabolism contributes to enterotoxigenic Bacteroides fragilis-induced colon tumorigenesis. Proc Natl Acad Sci USA. 2011; 108: 15354-9. doi: 10.1073/pnas.1010203108.
38. Rubinstein MR, Wang X, Liu W, Hao Y, Cai G, Han YW. Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/beta-catenin signaling via its FadA adhesin. Cell Host Microbe. 2013; 14:195-206. doi: 10.1016/j.chom.2013.07.012.
39. Elinav E, Nowarski R, Thaiss CA, Hu B, Jin C, Flavell RA. Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms. Nat Rev Cancer. 2013; 13:759-71. doi: 10.1038/nrc3611.
40. Nosho K, Irahara N, Shima K, Kure S, Kirkner GJ, Schernhammer ES, Hazra A, Hunter DJ, Quackenbush J, Spiegelman D, Giovannucci EL, Fuchs CS, Ogino S. Comprehensive biostatistical analysis of CpG island methylator phenotype in colorectal cancer using a large population-based sample. PLoS One. 2008; 3:e3698. doi: 10.1371/journal.pone.0003698.
41. Bos JL, Fearon ER, Hamilton SR, Verlaan-de Vries M, van Boom JH, van der Eb AJ, Vogelstein B. Prevalence of ras gene mutations in human colorectal cancers. Nature. 1987; 327:293-7. doi: 10.1038/327293a0.
42. Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, Teague J, Woffendin H, Garnett MJ, Bottomley W, Davis N, Dicks E, Ewing R, et al. Mutations of the BRAF gene in human cancer. Nature. 2002; 417:949-54. doi: 10.1038/nature00766.
43. Rajagopalan H, Bardelli A, Lengauer C, Kinzler KW, Vogelstein B, Velculescu VE. Tumorigenesis: RAF/RAS oncogenes and mismatch-repair status. Nature. 2002; 418:934. doi: 10.1038/418934a.
44. Siena S, Sartore-Bianchi A, Di Nicolantonio F, Balfour J, Bardelli A. Biomarkers predicting clinical outcome of epidermal growth factor receptor-targeted therapy in metastatic colorectal cancer. J Natl Cancer Inst. 2009; 101: 1308-24. doi: 10.1093/jnci/djp280.
45. Downward J. Ras signalling and apoptosis. Curr Opin Genet Dev. 1998; 8:49-54.
46. Winter SE, Lopez CA, Baumler AJ. The dynamics of gutassociated microbial communities during inflammation. EMBO Rep. 2013; 14:319-27. doi: 10.1038/embor.2013.27.
47. Jobin C. Colorectal cancer: CRC-all about microbial products and barrier function Nat Rev Gastroenterol Hepatol. 2012; 9:694-6. doi: 10.1038/nrgastro.2012.220.
48. Sandra Newbury, Mary K.blinn, Philip A. Bushby CBC, Julie D Dinnage, Brenda Griffin, Kate F Hurley, Natalie lsaza, Wes Jones, Lila Miller, Jeanette O'Quin, Gary J. Patronek, Martha Smith-blackmore, Miranda Spindel. Guidelines for Standards of Care in Animal Shelters. National Institutes of Health. 2010.
49. Chang WW. Histogenesis of symmetrical 1,2-dimethylhydrazine-induced neoplasms of the colon in the mouse. J Natl Cancer Inst. 1978; 60:1405-18.
50. Zhu Q, Jin Z, Wu W, Gao R, Guo B, Gao Z, Yang Y, Qin H. Analysis of the intestinal lumen microbiota in an animal model of colorectal cancer. PLoS One. 2014; 9:e90849. doi: 10.1371/journal.pone.0090849.
51. Chang WW. Morphological basis of multistep process in experimental colonic carcinogenesis. Virchows Arch B Cell Pathol Incl Mol Pathol. 1982; 41:17-37.
52. Chang WW. The mode of growth and compartmentalization of neoplastic glands during experimental colon carcinogenesis. Am J Pathol. 1986; 124:420-6.
53. Vandeputte DA, Troost D, Leenstra S, Ijlst-Keizers H, Ramkema M, Bosch DA, Baas F, Das NK, Aronica E. Expression and distribution of id helix-loop-helix proteins in human astrocytic tumors. Glia. 2002; 38:329-38. doi: 10.1002/glia.10076.